Prothena Corporation plc
PRTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $745 | $1,934 | $2,854 | $2,185 |
| - Cash | $471 | $619 | $710 | $579 |
| + Debt | $11 | $12 | $6 | $12 |
| Enterprise Value | $284 | $1,327 | $2,150 | $1,618 |
| Revenue | $135 | $91 | $54 | $201 |
| % Growth | 47.9% | 69.5% | -73.1% | – |
| Gross Profit | $135 | $91 | $54 | $201 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$154 | -$190 | -$131 | $73 |
| % Margin | -113.7% | -208.1% | -242.7% | 36.4% |
| Net Income | -$122 | -$147 | -$117 | $67 |
| % Margin | -90.5% | -160.9% | -217% | 33.4% |
| EPS Diluted | -2.27 | -2.76 | -2.47 | 1.38 |
| % Growth | 17.8% | -11.7% | -279% | – |
| Operating Cash Flow | -$150 | -$134 | -$109 | $93 |
| Capital Expenditures | -$0 | -$3 | -$0 | -$1 |
| Free Cash Flow | -$150 | -$137 | -$109 | $92 |